Major 10% Owners Sell $226.8M in LifeStance Health Stock
LFST has more than doubled off its 52-week low of $3.74.
Summary
Major 10% owners, including TPG, James G. Coulter, and Jon Winkelried, sold over $226 million worth of LifeStance Health Group stock, significantly reducing their stake.
Key Events · Ownership and Investor Activity · LFST
-
Significant Insider Sale
TPG GP A, LLC, James G. Coulter, and Jon Winkelried, identified as 10% owners, disposed of 28,281,943 shares of common stock.
-
Substantial Value
The open market sale on May 12, 2026, totaled $226,821,183 at a price of $8.02 per share.
-
Major Stake Reduction
This transaction represents over 20% of their prior holdings and approximately 7.4% of the company's market capitalization.
-
Follows Secondary Offering
This sale likely corresponds to the secondary offering of 35 million shares by selling stockholders, which was finalized on May 8, 2026.
Analysis · LFST · Industrial Applications And Services
TPG GP A, LLC, James G. Coulter, and Jon Winkelried, all significant 10% owners, reported a substantial open market sale of 28.28 million shares of LifeStance Health Group common stock for over $226 million. This transaction represents a significant reduction in their holdings, accounting for over 20% of their prior stake and a notable portion of the company's market capitalization. This sale likely relates to the recently announced secondary offering by selling stockholders, indicating a major divestment by these institutional investors.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 47.7% of the 1624 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LFST was trading at $7.91 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $3.74 to $8.89. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.